Cargando…

Expression and significance of urinary microRNA in patients with chronic hepatitis B

The aim of this study was to investigate the alterations of urinary microRNA (miRNA) expression and explore its clinical significance in patients with chronic hepatitis B (CHB). The expression levels of urinary miRNA were detected by miRNA microarray and quantitative reverse transcription polymerase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Jia-Wei, Yan, Xiu-Li, Zhang, Hui, Su, Shi-Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750300/ https://www.ncbi.nlm.nih.gov/pubmed/31517857 http://dx.doi.org/10.1097/MD.0000000000017143

Ejemplares similares

A simple noninvasive model to predict significant fibrosis in children with chronic hepatitis B
por: Zhang, Kang-Ling, et al.
Publicado: (2021)

Screening for microRNA-based diagnostic markers in hepatic alveolar echinococcosis
por: Ren, Bin, et al.
Publicado: (2019)

A Pilot Study of MicroRNAs Expression Profile in Serum and HBsAg Particles: Predictors of Therapeutic Vaccine Efficacy in Chronic Hepatitis B Patients
por: Wang, Weixia, et al.
Publicado: (2016)

Evaluation of the in situ assay for HBV DNA: An observational real-world study in chronic hepatitis B
por: Li, Chang, et al.
Publicado: (2021)

Identifying miRNA-mRNA regulation network of chronic pancreatitis based on the significant functional expression
por: Wang, Dan, et al.
Publicado: (2017)

Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
por: Lee, I-Cheng, et al.
Publicado: (2015)

A novel system for predicting liver histopathology in patients with chronic hepatitis B
por: Pan, An-Na, et al.
Publicado: (2017)

Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B: A Prospective Observational Study
por: Jia, Wei, et al.
Publicado: (2014)

Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection
por: Yan, Li-Ting, et al.
Publicado: (2020)

Expression and clinical significance of inhibitory receptor Leukocyte-associated immunoglobulin-like receptor-1 on peripheral blood T cells of chronic hepatitis B patients: A cross-sectional study
por: Gu, Yurong, et al.
Publicado: (2021)

Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases
por: Deng, Yong-Qiong, et al.
Publicado: (2015)

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients
por: Li, Min-Ran, et al.
Publicado: (2016)

Effect of tenofovir on renal function in patients with chronic hepatitis B
por: Jung, Woo Jin, et al.
Publicado: (2018)

Ischaemic colitis during pegylated interferon-alpha monotherapy for chronic hepatitis B: A case report
por: Liu, Yu, et al.
Publicado: (2022)

The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease
por: Liang, Jing, et al.
Publicado: (2016)

Comparison of collagen proportionate areas in liver fibrosis quantification between chronic hepatitis B and C
por: Chen, Sheng-Hung, et al.
Publicado: (2016)

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016)

Single-nucleotide polymorphism of rs7944135 (macrophage-expressed gene 1) is associated with hepatitis B surface antigen seroclearance in chronic hepatitis B infection: A cohort study
por: Irham, Lalu Muhammad, et al.
Publicado: (2019)

Increased A20 mRNA Level in Peripheral Blood Mononuclear Cells is Associated With Immune Phases of Patients With Chronic Hepatitis B
por: Sun, Yan-Yan, et al.
Publicado: (2015)

Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma
por: Ma, Qiang, et al.
Publicado: (2016)

Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B
por: Liu, Liang, et al.
Publicado: (2019)

Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients
por: Ungtrakul, Teerapat, et al.
Publicado: (2017)

Vitamin D serum level is associated with Child–Pugh score and metabolic enzyme imbalances, but not viral load in chronic hepatitis B patients
por: Zhao, Xin-yan, et al.
Publicado: (2016)

Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study
por: Zhu, Yun-Feng, et al.
Publicado: (2019)

One-year efficacy of tenofovir alafenamide in patients with chronic hepatitis B: An observational study
por: Chen, Yi-Cheng, et al.
Publicado: (2022)

Efficacy and safety of vesatolimod in chronic hepatitis B: A systematic review and meta-analysis
por: Omer, Ibrahim, et al.
Publicado: (2023)

The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China
por: Li, Qiang, et al.
Publicado: (2016)

A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B
por: Wang, Christina, et al.
Publicado: (2016)

Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients
por: Asil, Mehmet, et al.
Publicado: (2016)

Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate
por: Lee, Dohyeong, et al.
Publicado: (2019)

Improved Efficacy of a Pegylated Interferon-α-2a Stepwise Optimization Treatment Strategy in the Treatment of Hepatitis B e Antigen-positive Chronic Hepatitis B Patients
por: Zhou, Pu, et al.
Publicado: (2015)

Molecular expression profiles of selected microRNAs in colorectal adenocarcinoma in patients from south-eastern part of Romania
por: Brînzan, Costel, et al.
Publicado: (2019)

Expression and clinical significance of p62 protein in colon cancer
por: Lei, Cheng, et al.
Publicado: (2020)

Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study
por: Liu, Yanqiong, et al.
Publicado: (2015)

Preserved Function of Circulating Invariant Natural Killer T Cells in Patients With Chronic Hepatitis B Virus Infection
por: Zhu, Haoxiang, et al.
Publicado: (2015)

A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?
por: Oztas, Erkin, et al.
Publicado: (2015)

Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
por: Kim, Seung Up, et al.
Publicado: (2016)

Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease
por: Wang, Qi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k0140014rnrkgvfpgkioopdjnd